Notice of Registration - 2012
[Federal Register Volume 77, Number 246 (Friday, December 21, 2012)]
[Notices]
[Pages 75670-75671]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-30780]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances, Notice of Registration,
AMRI Rensselaer, Inc.
By Notice dated July 30, 2012, and published in the Federal
Register on August 7, 2012, 77 FR 47114, AMRI Rensselaer, Inc., 33
Riverside Avenue, Rensselaer, New York 12144, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as a bulk manufacturer of the following basic classes of controlled
substances:
| Drug |
Schedule |
| Marihuana (7360) |
I |
| Tetrahydrocannabinols (7370) |
I |
| Amphetamine (1100) |
II |
| Lisdexamfetamine (1205) |
II |
| Methylphenidate (1724) |
II |
| Pentobarbital (2270) |
II |
| 4-Anilino-N-phenethyl-4-piperidine (8333) |
II |
| Meperidine (9230) |
II |
| Fentanyl (9801) |
II |
The company plans to manufacture bulk controlled substances for use
in product development and for distribution to its customers.
In reference to drug code 7360 (Marihuana), the company plans to
bulk manufacture cannabidiol as a synthetic intermediate. This
controlled substance
[[Page 75671]]
will be further synthesized to bulk manufacture a synthetic THC (7370).
No other activity for this drug code is authorized for this
registration.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a), and determined that the registration
of AMRI Rensselaer, Inc., to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated AMRI Rensselaer, Inc., to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history.
Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR
1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: December 18, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-30780 Filed 12-20-12; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
